Heikki Koski, currently the Service Business and Development Director at Tamro, has been appointed as the CEO of Medaffcon Oy, effective from April 1, 2024. Medaffcon is a subsidiary of Tamro Oyj. The current CEO of Medaffcon, Jarmo Hahl, will continue to play a pivotal role in shaping the company's future in his new position leading the consulting business.
Selecting the right interactions is a key factor for success. Therefore, the client should also consider how well the partner understands the pharmaceutical industry's needs. When the partner has extensive hands-on experience from the industry, these irreplaceable insights enable the partner to guide the project at different strategic levels, ensuring that the client’s various needs can be identified and met.
In healthcare, there is a vast amount of data being generated and processed. Sometimes, its utilization is cumbersome because the data is scattered, and its analysis requires a lot of preprocessing.
We are remodeling the Health from Data Blog - The new name is "Health Data Site by Medaffcon", and it will have a fragment in our Newsletter
Sweden's publicly funded healthcare system and universal access to specialized health care make the data derived from Sweden broadly generalizable, covering diverse populations including different ethnic backgrounds.
Utilising the data lake of the Hospital District of Southwest Finland (TYKS), Medaffcon, Pfizer and TYKS have examined the clinical adoption of new medications for advanced renal cell carcinoma and the utility of data extracted without extensive manual extraction.
Coming up soon, Copenhagen will be the center of health economics as more than five thousand pharmaceutical and healthcare professionals gather for the ISPOR conference. ISPOR has been well known, especially among health economists. However, this years’ top trends real-world data (RWD) and real-world evidence (RWE) attract even wider audience.
Joining Medaffcon enables Dr. Johanna Simin to leverage her expertise to advance real-world data use and evidence-driven health. Medaffcon, in turn, can augment its in-house capabilities with the high-quality digital healthcare data found in Sweden.
Medaffcon has added Swedish healthcare registries to its capabilities as it continues to pursue growth and facilitate data utilisation by providing pharmaceutical companies access to rich and relevant healthcare data.
Single-arm research designs are challenging for a pharmaceutical reimbursement and marketing authorisation process.
Real World Evidence (RWE) ecosystem in Finland Real world data (RWD) is defined by FDA...
Medicines in Finland are divided into medicines in ambulatory and hospital care. This article describes...
The real world data (RWD) landscape in Finland offers globally unique data and possibilities to...
Pricing and reimbursement in Finland Pharmaceuticals Pricing Board (PPB), operating under the Ministry of Social...
Demonstrating that a health technology, e.g. a product, procedure or any intervention, is worth its...
Currently huge piles of health care data have been collected in Finland through national, regional...